A distribution yield hovering near 12% looks pretty attractive, but the fuel distributor severely lags the S&P 500 on one key metric.
The plastics distributor agreed to be acquired by Univar for a cool $2 billion.
This little-known company has piled up 24 consecutive quarters of year-over-year revenue growth.
The contract biologics manufacturer reported fiscal first-quarter 2019 earnings results.
The company is inching closer to commercializing its first major product.
The small-cap biopharma reported second-quarter 2018 earnings and two important business updates.
The company announced product updates and earned an extension to remain listed on the Nasdaq exchange -- for now.
The company reported second-quarter 2018 financial results and an important business update.
Believe it or not, share prices rose after the company announced a share offering.
The company announced and completed a share offering last month, but the timing worked out well.
The pharma company had a busy month of updates and progress.
The United States will be a net energy exporter no later than 2022. Liquefied natural gas, or LNG, will play a crucial role.
The additive manufacturing stock is up big in 2018 and approaching three-year highs.
The company's financial statements seem to indicate it's too dependent on federal and state subsidies. That's risky for individual investors.
The pharma company announced second-quarter 2018 earnings.
The company announced second-quarter 2018 earnings results and initiated a crucial late-stage clinical trial.
The genetic-testing leader reported strong second-quarter 2018 earnings results.
The nation's largest biodiesel producer reported second-quarter 2018 earnings and reached an important milestone.
The enzyme and protein manufacturer reported second-quarter 2018 earnings.
Mr. Market thinks the double-digit slide from July was overdone. He may be right.